Structural transformations of oligomeric intermediates in the fibrillation of the immunoglobulin light chain LEN

Biochemistry

Volumn 42, Issue 26, 2003, Pages 8094-8104

  Souillac, Pierre O ^a   Uversky, Vladimir N ^a   Fink, Anthony L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DESTABILIZING CONDITIONS;

OLIGOMERS; PROTEINS; STRUCTURE (COMPOSITION);

BIOCHEMISTRY;

AMYLOID; IMMUNOGLOBULIN LIGHT CHAIN; OLIGOMER; PROTEIN; PROTEIN LEN; SOLVENT; UNCLASSIFIED DRUG;

AGITATION; ARTICLE; CONCENTRATION RESPONSE; HUMAN; IMMUNOGLOBULIN VARIABLE REGION; KINETICS; MULTIPLE MYELOMA; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN SECONDARY STRUCTURE; PROTEIN STABILITY; SPECIES;

AMYLOID; AMYLOIDOSIS; ANILINO NAPHTHALENESULFONATES; CIRCULAR DICHROISM; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FLUORESCENCE POLARIZATION; FLUORESCENT DYES; HUMANS; HYDROGEN-ION CONCENTRATION; IMMUNOGLOBULIN LIGHT CHAINS; MULTIPLE MYELOMA; PROTEIN CONFORMATION; PROTEIN DENATURATION; SPECTROMETRY, FLUORESCENCE; SPECTROPHOTOMETRY, ULTRAVIOLET; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; THIAZOLES; TRYPTOPHAN;

EID: 0038047044     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi034652m     Document Type: Article

References (32)

1. Harper, J. D., Wong, S. S., Lieber, C. M., and Lansbury, P. T., Jr. (1999) Assembly of Aβ amyloid protofibrils: an in vitro model for a possible early event in Alzheimer's disease, Biochemistry 38, 8972-8980.
2. Uversky, V. N., Li, J., and Fink, A. L. (2001) Evidence for a partially folded intermediate in α-synuclein fibril formation, J. Biol. Chem. 276, 10737-10744.
3. Khurana, R., Gillespie, J. R., Talapatra, A., Minert, L. J., Ionescu-Zanetti, C., Millett, I. S., and Fink, A. L. (2001) Partially folded intermediates as critical precursors of light chain amyloid fibrils and amorphous aggregates, Biochemistry 40, 3525-3535.
4. Jiang, X., Smith, C. S., Petrassi, H. M., Hammarström, P., White, J. T., Sacchettini, J. C., and Kelly, J. W. (2001) An engineered transthyretin monomer that is nonamyloidogenic, unless it is partially denatured, Biochemistry 40, 11442-11452.
5. Solomon, A. (1985) Light chains of human immunoglobulin, in Methods in Enzymology (Di Sabato, G., Langone, J. J., Van Vunakis, H., Eds.) pp 101-121. Academic Press, San Diego, 116.
6. Solomon, A. Clinical implications of monoclonal light chains (1986) Semin. Oncology 13, 341-349.
7. Buxbaum, J. (1992) Mechanisms of disease; monoclonal immunoglobulin deposition. Amyloidosis, light chain deposition disease, and light chain and heavy chain deposition disease, Hematology-Oncology Clinics of North America 6, 323-346.
8. Wilkins Stevens, P., Raffen, R., Hanson, D. K., Deng, Y. L., Berrios-Hammond, M., Westholm, F. A., Murphy, C., Eulitz, M., Wetzel, R., Solomon, A., Schiffer, M., and Stevens, F. J. (1995) Recombinant immunoglobulin variable domains generated from synthetic genes provide a system for in vitro characterization of light-chain amyloid proteins, Protein Sci. 4, 421-432.
9. Souillac, P. O., Uversky, V. N., Millett, I. S., Khurana, R., Doniach, S., and Fink, A. L. (2002) Elucidation of the molecular mechanism during the early events in immunoglobulin light chain amyloid fibrillation: Evidence for an off-pathway oligomer, J. Biol. Chem. 277, 12666-12679.
10. Souillac, P. O., Uversky, V. N., Millett, I. S., Khurana, R., Doniach, S., and Fink, A. L. (2002) Effect of association state and conformational stability on the kinetics of immunoglobulin light chain amyloid fibril formation at physiological pH, J. Biol. Chem. 277, 12657-12665.
11. Kolmar, H., Frisch, C., Kleemann, G., Gotze, K., Stevens, F. J., and Fritz, H. J. (1994) Dimerization of Bence Jones proteins; linking the rate of transcription from an Escherichia coli promoter to the association constant of REIv, Biol. Chem. Hoppe-Seyler 375, 61-70.
12. Nielsen, L., Khurana, R., Coats, A., Frokjaer, S., Brange, J., Vyas, S., Uversky, V. N., and Fink, A. L. (2001) Effect of environmental factors on the kinetics of insulin fibril formation: elucidation of the molecular mechanism, Biochemistry 40, 6036-6046.
13. Pace, C. N., Shirley, B. A., and Thomson, J. A. (1996) Chapter 13: Measuring the conformational stability of a protein, in Protein Structure: A Practical Approach (Creighton, T. E., Ed.) IRL Press, Oxford.
14. B24]insulin mutants: a steady-state fluorescence anisotropy study, Biochemtry 36, 3430-3437.
15. Swaminathan, R., Nath, U., Udgaonkar, J. B., Periasamy, N., and Krishnamoorthy, G. (1996) Motional dynamics of a buried tryptophan reveals the presence of partially structured forms during denaturation of Barstar, Biochemistry 35, 9150-9157.
16. Sytnik, A. I., Chumachenko, Y. V., and Demchenko, A. P. (1991) Spectroscopic evidence for NADH-induced conformational changes in rabbit muscle aldolase, Biochim. Biophys. Acta 1079, 123-127.
17. Sreerama, N., Manning, M. C., Powers, M. E., Zhang, J. X., Goldenberg, D. P., and Woody, R. W. (1999) Tyrosine, phenylalanine, and disulfide contributions to the circular dichroism of proteins: circular dichroism spectra of wild-type and mutant bovine pancreatic trypsin inhibitor, Biochemistry 38, 10814-10822.
18. Eftink, M. R., and Selvidge, L. A. (1982) Fluorescence quenching of liver alcohol dehydrogenase by acrylamide, Biochemistry 21, 117-125.
19. gM proteins, Biochim. Biophys. Acta 535, 33-43.
20. France, R. M., and Grossman, S. H. (2000) Acrylamide quenching of apo- and holo-α-lactalbumin in guanidine hydrochloride, Biochem. Biophys. Res. Commun. 269, 709-712.
21. De Jongh, H. H. J., Goormaghtigh, E., and Ruysschaert, J. M. (1997) Monitoring structural stability of trypsin inhibitor at the submolecular level by amide-proton exchange using Fourier transform infrared spectroscopy: a test case for more general application, Biochemistry 36, 13593-13602.
22. De Jongh, H. H. J., Goormaghtigh, E., and Ruysschaert, J. M. (1997) Amide-proton exchange of water-soluble proteins of different structural classes studied at the submolecular level by infrared spectroscopy, Biochemistry 36, 13603-13610.
23. Raschke, T. M., and Marqusee, S. (1998) Hydrogen exchange studies of protein structure, Curr. Opin. Biotechnol. 9, 80-86.
24. Fontana, A., Zambonin, M., De Laureto, P. P., De Filippis, V., Clementi, A., and Scaramella, E. (1997) Probing the conformation state of apomyoglobin by limited proteolysis, J. Mol. Biol. 266, 223-230.
25. Hubbard, S. J. (1998) The structural aspects of limited proteolysis of native proteins, Biochim. Biophys. Acta 1382, 191-206.
26. De Laureto, P. P., Scaramella, E., Frigo, M., Wondrich, F. G., De Filippis, V., Zambonin, M., and Fontana, A. (1999) Protein Sci. 8, 2290-2303.
27. Spolaore, B., Bermejo, R., Zambonin, M., and Fontana, A. (2001) Protein interactions leading to conformational changes monitored by limited proteolysis: Apo form and fragments of horse cytochrome c, Biochemistry 40, 9460-9468.
28. Kheterpal, I., Williams, A., Murphy, C., Bledsoe, B., and Wetzel, R. (2001) Structural features of the Aβ amyloid fibril elucidated by limited proteolysis, Biochemistry 40, 11757-11767.
29. Oberg, K. A., and Fink, A. L. (1998) A new attenuated total reflectance Fourier transform infrared spectroscopy method for the study of proteins in solution, Anal. Biochem. 256, 2-106.
30. Fink, A. L., Seshadri, S., and Khurana, R. (1999) Attenuated total reflectance FTIR of aggregated proteins, Methods Enzymol. 309, 559-576.
31. Huang, D. B., Chang, C. H., Ainsworth, C., Johnson, G., Solomon, A., Stevens, F. J., and Schiffer, M. (1997) Variable domain structure of κIV human light chain LEN: high homology to the murine light chain McPC603, Mol. Immunol. 34, 1291-1301.
32. Khurana, R., Gillespie, J. R., Talapatra, A., Minert, L. J., Ionescu-Zanetti, C., Millett, I., and Fink, A. L. (2001) Biochemistry 40, 3525-3535.